These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 8413582)

  • 21. Dopamine receptor subtypes in the human pulmonary arterial tree.
    Ricci A; Mignini F; Tomassoni D; Amenta F
    Auton Autacoid Pharmacol; 2006 Oct; 26(4):361-9. PubMed ID: 16968475
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diversity of dopamine receptors: new molecular and pharmacological developments.
    Hartman DS; Lanau F
    Pol J Pharmacol; 1997 Aug; 49(4):191-9. PubMed ID: 9437762
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated D2 dopamine receptors in drug-naïve schizophrenics.
    Zeeberg BR; Gibson RE; Reba RC
    Science; 1988 Feb; 239(4841 Pt 1):789-91. PubMed ID: 2963379
    [No Abstract]   [Full Text] [Related]  

  • 24. Differential expression of dopamine D2 and D4 receptor and tyrosine hydroxylase mRNA in mice prone, or resistant, to chronic high-fat diet-induced obesity.
    Huang XF; Yu Y; Zavitsanou K; Han M; Storlien L
    Brain Res Mol Brain Res; 2005 Apr; 135(1-2):150-61. PubMed ID: 15857678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cortical localization of dopamine D4 receptors in the rat brain--immunocytochemical study.
    Wedzony K; Chocyk A; Maćkowiak M; Fijał K; Czyrak A
    J Physiol Pharmacol; 2000 Jun; 51(2):205-21. PubMed ID: 10898094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacological characterization of U-101387, a dopamine D4 receptor selective antagonist.
    Merchant KM; Gill GS; Harris DW; Huff RM; Eaton MJ; Lookingland K; Lutzke BS; Mccall RB; Piercey MF; Schreur PJ; Sethy VH; Smith MW; Svensson KA; Tang AH; Vonvoigtlander PF; Tenbrink RE
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1392-403. PubMed ID: 8968364
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Brain dopamine receptors: structure, functional role, and modulation by psychotropic substances].
    Raevskiĭ KS
    Vopr Med Khim; 1997; 43(6):553-65. PubMed ID: 9503573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Penile erection and yawning induced by dopamine D2-like receptor agonists in rats: influence of strain and contribution of dopamine D2, but not D3 and D4 receptors.
    Depoortère R; Bardin L; Rodrigues M; Abrial E; Aliaga M; Newman-Tancredi A
    Behav Pharmacol; 2009 Jul; 20(4):303-11. PubMed ID: 19584712
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tonic modulation of inhibition by dopamine D4 receptors in the rat hippocampus.
    Romo-Parra H; Aceves J; Gutiérrez R
    Hippocampus; 2005; 15(2):254-9. PubMed ID: 15476261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The dopamine D4 receptors and mechanisms of antipsychotic atypicality.
    Wong AH; Van Tol HH
    Prog Neuropsychopharmacol Biol Psychiatry; 2003 Oct; 27(7):1091-9. PubMed ID: 14642969
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Schizophrenia as a brain disease. The dopamine receptor story.
    Seeman P
    Arch Neurol; 1993 Oct; 50(10):1093-5. PubMed ID: 8215969
    [No Abstract]   [Full Text] [Related]  

  • 32. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Buchsbaum MS
    Neuropsychopharmacology; 1992 Aug; 7(1):67-8; discussion 73-5. PubMed ID: 1355970
    [No Abstract]   [Full Text] [Related]  

  • 33. Integrating the neurobiology of schizophrenia. Preface.
    Abi-Dargham A; Guillin O
    Int Rev Neurobiol; 2007; 78():xiii-xvi. PubMed ID: 17349855
    [No Abstract]   [Full Text] [Related]  

  • 34. D3 dopamine receptor mRNA is elevated in T cells of schizophrenic patients whereas D4 dopamine receptor mRNA is reduced in CD4+ -T cells.
    Boneberg EM; von Seydlitz E; Pröpster K; Watzl H; Rockstroh B; Illges H
    J Neuroimmunol; 2006 Apr; 173(1-2):180-7. PubMed ID: 16376996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Schizophrenia as a dopamine excess syndrome].
    Toru M
    Nihon Rinsho; 1983 May; 41(5):1021-7. PubMed ID: 6138444
    [No Abstract]   [Full Text] [Related]  

  • 36. Dopamine receptors--the present state of research and perspectives.
    Wolfarth S; Ossowska K
    Pol J Pharmacol; 1995; 47(3):207-18. PubMed ID: 8714754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lack of association between dopamine D4 receptor gene and schizophrenia.
    Tanaka T; Igarashi S; Onodera O; Tanaka H; Kameda K; Takahashi K; Tsuji S; Ihda S
    Am J Med Genet; 1995 Dec; 60(6):580-2. PubMed ID: 8825901
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Biochemical aspects of schizophrenia.
    Lewis ME
    Essays Neurochem Neuropharmacol; 1980; 4():1-67. PubMed ID: 6104597
    [No Abstract]   [Full Text] [Related]  

  • 39. Dopamine receptors in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1996 Jan; 347(8996):264. PubMed ID: 8551909
    [No Abstract]   [Full Text] [Related]  

  • 40. In vivo assessment of dopaminergic variables in schizophrenia.
    Martinot JL; Paillere-Martinot ML; Lecrubier Y; Dao-Castellana MH; Loc'h C; Poirier MF; Allilaire JF; Feline A; Manus A; Aubin F
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():470A-471A. PubMed ID: 1354053
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.